Stem Cell Prepa­ra­tions

Haematopoietic stem cells (blood stem cells) are responsible for the regeneration of blood cells with their various tasks, e.g. oxygen transport, wound closure and immune defence.

Haematopoietic stem cell preparations are obtained from blood in circulation, from bone marrow or from cord blood and then placed in an anticoagulant solution. They are used fresh or are deep-frozen at temperatures below -140°C; for stem cell transplantation, stem cell preparations from the patient (autologous) or obtained from a donor (allogeneic) can be used.

Search results 351 to 356 from a total of 356

Name Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date Further Information

Stam­mzel­lzu­bere­itung aus al­lo­gen­em Knochen­mark- HOM, frisch

Uni­ver­sität­sklinikum des Saar­lan­des

PEI.G.04151.01.1 15.12.2011

Stam­mzel­lzu­bere­itung aus au­tolo­gem Knochen­mark- HOM, vol­u­menre­duziert, kryokon­serviert

Uni­ver­sität­sklinikum des Saar­lan­des

PEI.G.04150.01.1 18.01.2012

Stam­mzel­lzu­bere­itung und Kryokon­servierung aus au­tolo­gem pe­riph­erem Blut WPK

Westp­falz-Klinikum GmbH

PEI.G.03688.01.1 14.12.2011

Stam­mzel­lzu­bere­itung, al­lo­gen (L)

Uni­ver­sität­sklinikum Leipzig A.ö.R.

PEI.G.03719.01.1 29.11.2010

TCRαβ/CD19-de­pletierte al­loPB­SC SZTWü

Uni­ver­sität­sklinikum Würzburg

PEI.H.12000.01.1 31.03.2020

TCRαβ/CD19-de­pletierte kryokon­servierte al­loPB­SC SZTWü

Uni­ver­sität­sklinikum Würzburg

PEI.H.12000.02.1 31.03.2020



The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 486 in BAnz AT 28.10.2021 B3.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 28.10.2021